Please enable JavaScript to continue using this application.

Compare $ALMR vs $PSNL | Chartloom

Compare

$ALMR vs $PSNL

Alamar Biosciences Inc · Personalis Inc

ALMR

Alamar Biosciences Inc

PSNL

Personalis Inc

Compare $ALMR vs $PSNL

Comparing Alamar Biosciences Inc and Personalis Inc

ALMRAlamar Biosciences Inc

PSNLPersonalis Inc

ALMRAlamar Biosciences Inc

Market cap

$1.75B

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

12.35x

Rev growth (TTM)

—

YTD performance

14.9%

52W performance

14.9%

FCF yield

0.0%

PSNLPersonalis Inc

Market cap

$1.71B

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

17.58x

Rev growth (TTM)

-13.3%

YTD performance

103.8%

52W performance

84.3%

FCF yield

-5.9%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

ALMR

PSNL

Detailed metrics comparison

ALMR

Alamar Biosciences Inc

PSNL

Personalis Inc

Market Cap

ALMR$1.75B

PSNL$1.71B

Enterprise Value

ALMR$1.63B

PSNL$1.61B

Price

ALMR$25.27

PSNL$16.00

P/E Ratio

ALMRN/A

PSNLN/A

P/S Ratio

ALMR31.58x

PSNL24.52x

EV/Sales

ALMR29.36x

PSNL23.18x

EV/EBITDA

ALMR0.00x

PSNL0.00x

P/B Ratio

ALMR7.62x

PSNL7.39x

P/FCF Ratio

ALMRN/A

PSNLN/A

EV/FCF

ALMR0.00x

PSNL-15.99x

PEG Ratio

ALMRN/A

PSNLN/A

Forward P/E (NTM)

ALMRN/A

PSNLN/A

Forward P/S (NTM)

ALMR12.35x

PSNL17.58x

Revenue (TTM)

ALMR$55M

PSNL$70M

Revenue Growth (YoY)

ALMRN/A

PSNL-13.3%

Forward Rev Growth

ALMR39.6%

PSNL37.3%

Gross Margin (TTM)

ALMR58.0%

PSNL12.7%

Operating Margin (TTM)

ALMR0.0%

PSNL0.0%

EBITDA Margin (TTM)

ALMR-45.8%

PSNL-150.1%

Net Margin (TTM)

ALMR-62.2%

PSNL-153.8%

FCF Margin (TTM)

ALMR0.0%

PSNL-144.9%

Net Income (TTM)

ALMR$-35M

PSNL$-107M

FCF (TTM)

ALMR$0

PSNL$-101M

EPS (TTM)

ALMR-$0.50

PSNL-$1.02

ROE (TTM)

ALMR0.0%

PSNL-4647.0%

ROA (TTM)

ALMR0.0%

PSNL-3530.0%

ROIC (TTM)

ALMR0.0%

PSNL-4601.0%

Cash

ALMR$133M

PSNL$94M

Debt

ALMR$10M

PSNL$898K

Net Cash/Debt

ALMR$123M

PSNL$93M

Current Ratio (TTM)

ALMR11.85x

PSNL5.28x

Quick Ratio (TTM)

ALMR9.67x

PSNL4.91x

Debt/Equity (TTM)

ALMR0.03x

PSNL0.00x

Debt/Assets (TTM)

ALMR0.0%

PSNL0.0%

Interest Coverage (TTM)

ALMRN/A

PSNLN/A

Net Debt/EBITDA (TTM)

ALMR0.00x

PSNL0.00x

Beta

ALMR-0.30

PSNL2.37

52W Performance

ALMR14.9%

PSNL84.3%

YTD Performance

ALMR14.9%

PSNL103.8%

% from 52W High

ALMR-36.2%

PSNL-15.3%

% from 52W Low

ALMR34.1%

PSNL222.9%

Asset Turnover (TTM)

ALMR0.00x

PSNL0.23x

FCF Yield (TTM)

ALMR0.0%

PSNL-5.9%

Earnings Yield (TTM)

ALMR-2.0%

PSNL-6.3%

Dividend Yield (TTM)

ALMRN/A

PSNLN/A

Rule of 40

ALMR0.0

PSNL-158.2

EV/GP/RG

ALMR0.30

PSNL4.29

Ticker research

View ALMR research View PSNL research

Metric	ALMR Alamar Biosciences Inc	PSNL Personalis Inc
Market & Valuation
Market Cap	$1.75B	$1.71B
Enterprise Value	$1.63B	$1.61B
Price	$25.27	$16.00
P/E Ratio	N/A	N/A
P/S Ratio	31.58x	24.52x
EV/Sales	29.36x	23.18x
EV/EBITDA	0.00x	0.00x
P/B Ratio	7.62x	7.39x
P/FCF Ratio	N/A	N/A
EV/FCF	0.00x	-15.99x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	12.35x	17.58x
Revenue & Growth
Revenue (TTM)	$55M	$70M
Revenue Growth (YoY)	N/A	-13.3%
Forward Rev Growth	39.6%	37.3%
Profitability
Gross Margin (TTM)	58.0%	12.7%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-45.8%	-150.1%
Net Margin (TTM)	-62.2%	-153.8%
FCF Margin (TTM)	0.0%	-144.9%
Net Income (TTM)	$-35M	$-107M
FCF (TTM)	$0	$-101M
EPS (TTM)	-$0.50	-$1.02
ROE (TTM)	0.0%	-4647.0%
ROA (TTM)	0.0%	-3530.0%
ROIC (TTM)	0.0%	-4601.0%
Financial Health
Cash	$133M	$94M
Debt	$10M	$898K
Net Cash/Debt	$123M	$93M
Current Ratio (TTM)	11.85x	5.28x
Quick Ratio (TTM)	9.67x	4.91x
Debt/Equity (TTM)	0.03x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	-0.30	2.37
52W Performance	14.9%	84.3%
YTD Performance	14.9%	103.8%
% from 52W High	-36.2%	-15.3%
% from 52W Low	34.1%	222.9%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.23x
FCF Yield (TTM)	0.0%	-5.9%
Earnings Yield (TTM)	-2.0%	-6.3%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	-158.2
EV/GP/RG	0.30	4.29
Ticker research	View ALMR research	View PSNL research

Valuation

P/S Ratio

PSNL

24.52x

ALMR

31.58x

EV/FCF

PSNL

-15.99x

ALMR

0.00x

Growth & revenue

Revenue Growth TTM

PSNL

-13.3%

Forward Revenue Growth

ALMR

39.6%

PSNL

37.3%

Profitability & performance

Gross Margin

ALMR

58.0%

PSNL

12.7%

ROE

ALMR

0.0%

PSNL

-4647.0%

FCF Yield %

ALMR

0.0%

PSNL

-5.9%

52-Week Performance

PSNL

84.3%

ALMR

14.9%

Detailed metrics comparison

ALMR

Alamar Biosciences Inc

PSNL

Personalis Inc

Market Cap

ALMR$1.75B

PSNL$1.71B

Enterprise Value

ALMR$1.63B

PSNL$1.61B

Price

ALMR$25.27

PSNL$16.00

P/E Ratio

ALMRN/A

PSNLN/A

P/S Ratio

ALMR31.58x

PSNL24.52x

EV/Sales

ALMR29.36x

PSNL23.18x

EV/EBITDA

ALMR0.00x

PSNL0.00x

P/B Ratio

ALMR7.62x

PSNL7.39x

P/FCF Ratio

ALMRN/A

PSNLN/A

EV/FCF

ALMR0.00x

PSNL-15.99x

PEG Ratio

ALMRN/A

PSNLN/A

Forward P/E (NTM)

ALMRN/A

PSNLN/A

Forward P/S (NTM)

ALMR12.35x

PSNL17.58x

Revenue (TTM)

ALMR$55M

PSNL$70M

Revenue Growth (YoY)

ALMRN/A

PSNL-13.3%

Forward Rev Growth

ALMR39.6%

PSNL37.3%

Gross Margin (TTM)

ALMR58.0%

PSNL12.7%

Operating Margin (TTM)

ALMR0.0%

PSNL0.0%

EBITDA Margin (TTM)

ALMR-45.8%

PSNL-150.1%

Net Margin (TTM)

ALMR-62.2%

PSNL-153.8%

FCF Margin (TTM)

ALMR0.0%

PSNL-144.9%

Net Income (TTM)

ALMR$-35M

PSNL$-107M

FCF (TTM)

ALMR$0

PSNL$-101M

EPS (TTM)

ALMR-$0.50

PSNL-$1.02

ROE (TTM)

ALMR0.0%

PSNL-4647.0%

ROA (TTM)

ALMR0.0%

PSNL-3530.0%

ROIC (TTM)

ALMR0.0%

PSNL-4601.0%

Cash

ALMR$133M

PSNL$94M

Debt

ALMR$10M

PSNL$898K

Net Cash/Debt

ALMR$123M

PSNL$93M

Current Ratio (TTM)

ALMR11.85x

PSNL5.28x

Quick Ratio (TTM)

ALMR9.67x

PSNL4.91x

Debt/Equity (TTM)

ALMR0.03x

PSNL0.00x

Debt/Assets (TTM)

ALMR0.0%

PSNL0.0%

Interest Coverage (TTM)

ALMRN/A

PSNLN/A

Net Debt/EBITDA (TTM)

ALMR0.00x

PSNL0.00x

Beta

ALMR-0.30

PSNL2.37

52W Performance

ALMR14.9%

PSNL84.3%

YTD Performance

ALMR14.9%

PSNL103.8%

% from 52W High

ALMR-36.2%

PSNL-15.3%

% from 52W Low

ALMR34.1%

PSNL222.9%

Asset Turnover (TTM)

ALMR0.00x

PSNL0.23x

FCF Yield (TTM)

ALMR0.0%

PSNL-5.9%

Earnings Yield (TTM)

ALMR-2.0%

PSNL-6.3%

Dividend Yield (TTM)

ALMRN/A

PSNLN/A

Rule of 40

ALMR0.0

PSNL-158.2

EV/GP/RG

ALMR0.30

PSNL4.29

Ticker research

View ALMR research View PSNL research

Metric	ALMR Alamar Biosciences Inc	PSNL Personalis Inc
Market & Valuation
Market Cap	$1.75B	$1.71B
Enterprise Value	$1.63B	$1.61B
Price	$25.27	$16.00
P/E Ratio	N/A	N/A
P/S Ratio	31.58x	24.52x
EV/Sales	29.36x	23.18x
EV/EBITDA	0.00x	0.00x
P/B Ratio	7.62x	7.39x
P/FCF Ratio	N/A	N/A
EV/FCF	0.00x	-15.99x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	12.35x	17.58x
Revenue & Growth
Revenue (TTM)	$55M	$70M
Revenue Growth (YoY)	N/A	-13.3%
Forward Rev Growth	39.6%	37.3%
Profitability
Gross Margin (TTM)	58.0%	12.7%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-45.8%	-150.1%
Net Margin (TTM)	-62.2%	-153.8%
FCF Margin (TTM)	0.0%	-144.9%
Net Income (TTM)	$-35M	$-107M
FCF (TTM)	$0	$-101M
EPS (TTM)	-$0.50	-$1.02
ROE (TTM)	0.0%	-4647.0%
ROA (TTM)	0.0%	-3530.0%
ROIC (TTM)	0.0%	-4601.0%
Financial Health
Cash	$133M	$94M
Debt	$10M	$898K
Net Cash/Debt	$123M	$93M
Current Ratio (TTM)	11.85x	5.28x
Quick Ratio (TTM)	9.67x	4.91x
Debt/Equity (TTM)	0.03x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	-0.30	2.37
52W Performance	14.9%	84.3%
YTD Performance	14.9%	103.8%
% from 52W High	-36.2%	-15.3%
% from 52W Low	34.1%	222.9%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.23x
FCF Yield (TTM)	0.0%	-5.9%
Earnings Yield (TTM)	-2.0%	-6.3%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	-158.2
EV/GP/RG	0.30	4.29
Ticker research	View ALMR research	View PSNL research